Evidence supporting the use of: Branched-Chain Amino Acids
For the health condition: Nephritis

Links: Go back one page, Tool main page, Ingredients list, Health conditions list, Body systems list

Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Branched-Chain Amino Acids (BCAAs) have been studied in the context of nephritis, particularly in relation to chronic kidney disease (CKD) and nephrotic syndrome, where protein metabolism and nutritional status are often compromised. Scientific evidence suggests that BCAAs may have a role in supporting nutritional needs in patients with nephritis who develop protein-energy malnutrition or hypoalbuminemia. Several clinical studies, primarily in Japan, have assessed the impact of BCAA supplementation on serum albumin levels and protein status in patients with chronic renal disease. Some findings indicate that BCAA supplementation can help maintain or slightly increase serum albumin levels, particularly in patients who are receiving low-protein diets as part of their nephritis management. This may improve nutritional status and potentially quality of life. However, the evidence is not robust. Most studies are small, short-term, or lack rigorous controls, and the clinical outcomes (such as improvements in renal function, survival, or reduction in nephritis activity) are not consistently demonstrated. Additionally, international guidelines do not strongly endorse routine BCAA supplementation for nephritis, reserving its use for specific cases of protein-energy wasting. There is no substantial evidence to suggest that BCAAs directly treat nephritis or its underlying inflammation. Thus, while some scientific rationale exists for their supportive use in malnutrition associated with nephritis, the overall evidence is modest.

More about Branched-Chain Amino Acids
More about Nephritis

Products containing Branched-Chain Amino Acids

We currently have no products on Vitabase that contain this ingredient.